Jenburkt Pharma - Quaterly Results

23 May 2023 Evaluate
The revenue zoomed 24.42% to Rs. 351.99 millions for the quarter ended March 2023 as compared to Rs. 282.90 millions during the corresponding quarter last year.Net profit surges 84.28% to Rs. 63.54  millions  from Rs. 34.48 millions in the quarter ended March 2023.Operating profit for the quarter ended March 2023 rose to 87.54 millions as compared to 59.30 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202203 202103 % Var
Sales 351.99 282.90 24.42 1367.49 1239.80 10.30 1239.80 1092.94 13.44
Other Income 12.56 12.78 -1.72 51.24 49.49 3.54 49.49 43.08 14.88
PBIDT 87.54 59.30 47.62 354.91 322.02 10.21 322.04 241.52 33.34
Interest 0.84 1.21 -30.58 3.67 4.34 -15.44 4.35 4.74 -8.23
PBDT 86.70 58.09 49.25 351.24 317.68 10.56 317.69 236.78 34.17
Depreciation 5.94 5.38 10.41 22.58 18.99 18.90 18.99 20.35 -6.68
PBT 80.76 52.71 53.22 328.66 298.69 10.03 298.70 216.43 38.01
TAX 17.22 18.23 -5.54 82.58 75.74 9.03 75.74 51.39 47.38
Deferred Tax 1.62 4.73 -65.75 -2.25 2.96 -176.01 2.96 -3.91 -175.70
PAT 63.54 34.48 84.28 246.08 222.95 10.37 222.96 165.04 35.09
Equity 44.13 45.89 -3.84 45.89 45.89 0.00 45.89 45.89 0.00
PBIDTM(%) 24.87 20.96 18.65 25.95 25.97 -0.08 25.98 22.10 17.54

Jenburkt Pharma Share Price

1009.85 -8.15 (-0.80%)
09-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.10
Dr. Reddys Lab 1095.15
Cipla 1416.30
Lupin 1921.30
Zydus Lifesciences 844.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...